Development and Validation of a Quantitative Measure of Adaptive Behaviors in Women With Pelvic Floor Disorders

Overview

Journal Female Pelvic Med Reconstr Surg

Date 2017 Jun 27

PMID 28650896

Citations 11

Authors

John T Wei

Rodney Dunn

Ingrid Nygaard

Kathryn Burgio

Emily S Lukacz

Alayne Markland

Patricia A Wren

Linda Brubaker

Matthew D Barber

J Eric Jelovsek

Cathie Spino

Susie Meikle

Nancy Janz

Affiliations

Soon will be listed here.

Abstract

Purpose: To establish validity for the Pelvic Floor Disorders Network (PFDN) self-administered Adaptive Behavior Index (ABI) and to assess whether ABI assesses known discordance between severity of pelvic floor symptoms and self-reported bother.

Methods: In addition to the ABI questionnaire, participants in 1 of 6 Pelvic Floor Disorders Network trials completed condition-specific measures of pretreatment symptom severity (including Pelvic Floor Distress Inventory; PFDI) and health-related quality of life (Pelvic Floor Impact Questionnaire; PFIQ). The final survey was developed from an iterative process using subject and expert endorsement, factor analyses, and response distributions. Domains were created using a development cohort (n = 304 women), reliability and validity were established using a validation cohort (n = 596 women), and test-retest reliability was assessed (n = 111 women).

Results: Factor analyses supported an 11-item avoidance domain and a 6-item hygiene domain. Cronbach' alphas were 0.88 and 0.68, respectively. Test-retest reliability was 0.84 for both domains. Construct validity was demonstrated in correlations between the ABI domains and baseline PFDI and PFIQ (r values, 0.43-0.79 with all P values <0.0001). Moreover, the ABI accounted for 8% to 26% of unexplained variance between the symptoms severity measure and the impact on health related quality of life. After treatment, avoidance domain scores improved for urinary and fecal incontinence groups and hygiene scores improved for the fecal incontinence group.

Conclusions: The ABI is a reliable and valid measure in women with pelvic floor disorders. Adaptive behaviors account in part for discordance between pelvic floor symptom severity and bother.

Citing Articles

The Pelvic Floor Disorders Network: Evolution Over Two Decades of Female Pelvic Floor Research.

Richter H, Visco A, Brubaker L, Sung V, Nygaard I, Arya L Urogynecology (Phila). 2025; 30(10):854-869.

PMID: 39752613 PMC: 11706353. DOI: 10.1097/SPV.0000000000001571.

Optimizing remote access to urinary incontinence treatments for women veterans (PRACTICAL): Study protocol for a pragmatic clinical trial comparing two virtual care options.

Markland A, Vaughan C, Goldstein K, Hastings S, Kelly U, Beasley T Contemp Clin Trials. 2023; 133:107328.

PMID: 37659594 PMC: 10591807. DOI: 10.1016/j.cct.2023.107328.

Patient-Reported Outcome Measures for Use in Women With Pelvic Organ Prolapse: A Systematic Review.

Dieter A, Halder G, Pennycuff J, Singh R, El-Nashar S, Lipetskaia L Obstet Gynecol. 2023; 141(6):1098-1114.

PMID: 37073897 PMC: 10524573. DOI: 10.1097/AOG.0000000000005212.

Validation of bladder health scales and function indices for women's research.

Constantine M, Rockwood T, Rickey L, Bavendam T, Low L, Lowder J Am J Obstet Gynecol. 2023; 228(5):566.e1-566.e14.

PMID: 36596439 PMC: 10425263. DOI: 10.1016/j.ajog.2022.12.319.

Design of a Randomized Controlled Trial of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Refractory Fecal Incontinence in Women: The NeurOmodulaTion for Accidental Bowel Leakage Study.

Zyczynski H, Arya L, Lukacz E, Richter H, Rahn D, Sung V Female Pelvic Med Reconstr Surg. 2021; 27(12):726-734.

PMID: 33950027 PMC: 8567096. DOI: 10.1097/SPV.0000000000001050.

References

Jelovsek J, Barber M . Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol. 2006; 194(5):1455-61. DOI: 10.1016/j.ajog.2006.01.060. View

Handa V, Harvey L, Cundiff G, Siddique S, Kjerulff K . Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol. 2004; 191(3):751-6. DOI: 10.1016/j.ajog.2003.11.017. View

Wei J, Nygaard I, Richter H, Nager C, Barber M, Kenton K . A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med. 2012; 366(25):2358-67. PMC: 3433843. DOI: 10.1056/NEJMoa1111967. View

Rockwood T, Church J, Fleshman J, Kane R, Mavrantonis C, Thorson A . Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence. Dis Colon Rectum. 2000; 43(1):9-16; discussion 16-7. DOI: 10.1007/BF02237236. View

Fitzgerald M, Janz N, Wren P, Wei J, Weber A, Ghetti C . Prolapse severity, symptoms and impact on quality of life among women planning sacrocolpopexy. Int J Gynaecol Obstet. 2007; 98(1):24-8. DOI: 10.1016/j.ijgo.2007.03.018. View

Barber M, Brubaker L, Menefee S, Norton P, Borello-France D, Varner E . Operations and pelvic muscle training in the management of apical support loss (OPTIMAL) trial: design and methods. Contemp Clin Trials. 2009; 30(2):178-89. PMC: 2646798. DOI: 10.1016/j.cct.2008.12.001. View

Bump R, Mattiasson A, Bo K, Brubaker L, DeLancey J, Klarskov P . The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996; 175(1):10-7. DOI: 10.1016/s0002-9378(96)70243-0. View

Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, BRATT H . Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Community Health. 1993; 47(6):497-9. PMC: 1059866. DOI: 10.1136/jech.47.6.497. View

Coyne K, Kvasz M, Ireland A, Milsom I, Kopp Z, Chapple C . Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. Eur Urol. 2011; 61(1):88-95. DOI: 10.1016/j.eururo.2011.07.049. View

10.

Brown H, Wexner S, Segall M, Brezoczky K, Lukacz E . Quality of life impact in women with accidental bowel leakage. Int J Clin Pract. 2012; 66(11):1109-16. DOI: 10.1111/ijcp.12017. View

11.

Perry S, Shaw C, McGrother C, Matthews R, Assassa R, Dallosso H . Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut. 2002; 50(4):480-4. PMC: 1773171. DOI: 10.1136/gut.50.4.480. View

12.

Nygaard I, Barber M, Burgio K, Kenton K, Meikle S, Schaffer J . Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008; 300(11):1311-6. PMC: 2918416. DOI: 10.1001/jama.300.11.1311. View

13.

Harris S, Link C, Tennstedt S, Kusek J, McKinlay J . Care seeking and treatment for urinary incontinence in a diverse population. J Urol. 2007; 177(2):680-4. DOI: 10.1016/j.juro.2006.09.045. View

14.

Wilson I, Cleary P . Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 1995; 273(1):59-65. View

15.

Handa V, Zyczynski H, Burgio K, Fitzgerald M, Borello-France D, Janz N . The impact of fecal and urinary incontinence on quality of life 6 months after childbirth. Am J Obstet Gynecol. 2007; 197(6):636.e1-6. PMC: 3076510. DOI: 10.1016/j.ajog.2007.08.020. View

16.

Melville J, Fan M, Rau H, Nygaard I, Katon W . Major depression and urinary incontinence in women: temporal associations in an epidemiologic sample. Am J Obstet Gynecol. 2009; 201(5):490.e1-7. DOI: 10.1016/j.ajog.2009.05.047. View

17.

Barber M, Kuchibhatla M, Pieper C, Bump R . Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol. 2001; 185(6):1388-95. DOI: 10.1067/mob.2001.118659. View

18.

Felde G, Bjelland I, Hunskaar S . Anxiety and depression associated with incontinence in middle-aged women: a large Norwegian cross-sectional study. Int Urogynecol J. 2011; 23(3):299-306. DOI: 10.1007/s00192-011-1564-3. View

19.

Brubaker L, Richter H, Visco A, Mahajan S, Nygaard I, Braun T . Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol. 2008; 180(1):217-22. PMC: 2597793. DOI: 10.1016/j.juro.2008.03.028. View

20.

Visco A, Brubaker L, Richter H, Nygaard I, Paraiso M, Menefee S . Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med. 2012; 367(19):1803-13. PMC: 3543828. DOI: 10.1056/NEJMoa1208872. View